BHVN Q4 2022 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$213M

Net Income

-$201M

EPS (Diluted)

$-3.30

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$76M

Stock-Based Comp.

$116M

Balance Sheet

Total Assets

$662M

Total Liabilities

$123M

Stockholders' Equity

$539M

Cash & Equivalents

$205M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$213M	-$51M	-319.4%
Net Income	-$201M	-$52M	-287.6%